Design and application of intelligent medication management program for liver transplant recipients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040346

Enrollment

Unknown

Registered

2020-11-28

Start date

2020-11-13

Completion date

Unknown

Last updated

2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation

Interventions

Case series:Using drug management software

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Liver transplant recipients are currently taking at least one immunosuppressant; 2. Discharged from hospital for more than 30 days; 3. Aged 18 to 65 years old; 4. Proficient in using smart phones; 5. Stable liver function and immunosuppressant concentration; 6. Volunteer to participate in the study for at least 6 months.

Exclusion criteria

Exclusion criteria: 1. Recipients of organ transplantation; 2. Patients with tumor or other serious diseases; 3. Using other drug compliance related electronic products.

Design outcomes

Primary

Measure	Time frame
Drug compliance;	—

Secondary

Measure	Time frame
Drug knowledge;	—

Countries

China

Contacts

Public ContactLin Zhang

The First Affiliated Hospital of Medical College of Zhejiang University

springzyyy@yeah.net+86 13957162852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026